Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Fatigue 5cyclopia sequence 1Sleepiness 1Parasomnias 1Pain 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Depression 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Anorexia 1

Interventions

Magnetic Resonance Spectroscopy 8Radiotherapy 7Temozolomide 5Carboplatin 5Vincristine 4etoposide phosphate 3Methotrexate 3Etoposide 3Busulfan 3Biopsy 3Thiotepa 2Surveys and Questionnaires 2Melphalan 2Magnetic Resonance Imaging 2Lomustine 2Cisplatin 2Chemotherapy, Adjuvant 2alovudine 1Yoga 1Ursodeoxycholic Acid 1Topotecan 1Stem Cell Transplantation 1Rituximab 1Remote Consultation 1Radiation 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Oxycodone 1Ocoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Central Nervous System Neoplasms × Modafinil × Clear all
NCT00052286 2020-08-03

Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer

Jonsson Comprehensive Cancer Center

Phase NA Completed
29 enrolled
CNS

Brain Neoplasms, Fatigue, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡